Estrogen receptor β, a regulator of androgen receptor signaling in the mouse ventral prostate

EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer

(2017) Philip Cornford et al.   EUROPEAN UROLOGY

Synthesis and structure–activity relationships of 1-benzylindane derivatives as selective agonists for estrogen receptor beta

(2016) Shigeru Yonekubo et al.   BIOORGANIC & MEDICINAL CHEMISTRY

ROR-γ drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer

(2016) Junjian Wang et al.   NATURE MEDICINE

Targeting the androgen receptor in metastatic castrate-resistant prostate cancer: A review

(2016) Archana Anantharaman et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Selective Estrogen Receptor β Agonist LY500307 as a Novel Therapeutic Agent for Glioblastoma

(2016) Gangadhara R. Sareddy et al.   Scientific Reports

An ERβ agonist induces browning of subcutaneous abdominal fat pad in obese female mice

(2016) Yi-fei Miao et al.   Scientific Reports

The Endogenous Cell-Fate Factor Dachshund Restrains Prostate Epithelial Cell Migration via Repression of Cytokine Secretion via a CXCL Signaling Module

(2015) K. Chen et al.   CANCER RESEARCH

Highly Selective Salicylketoxime-Based Estrogen Receptor β Agonists Display Antiproliferative Activities in a Glioma Model

(2015) Ilaria Paterni et al.   JOURNAL OF MEDICINAL CHEMISTRY

Ndfip1 represses cell proliferation by controlling Pten localization and signaling specificity

(2015) Jason Howitt et al.   Journal of Molecular Cell Biology

The humanNUPR1/P8gene is transcriptionally activated by transforming growth factor β via the SMAD signalling pathway

(2015) Roxane M. Pommier et al.   BIOCHEMICAL JOURNAL

Changes in Estrogen Receptor ERβ (ESR2) Expression without Changes in the Estradiol Levels in the Prostate of Aging Rats

(2015) Mônica Morais-Santos et al.   PLoS One

Epigenetic silencing ofDACH1induces the invasion and metastasis of gastric cancer by activating TGF-β signalling

(2014) Wenji Yan et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Estrogen receptor beta agonist LY500307 fails to improve symptoms in men with enlarged prostate secondary to benign prostatic hypertrophy

(2014) C G Roehrborn et al.   PROSTATE CANCER AND PROSTATIC DISEASES

Estrogen receptors alpha (ERα) and beta (ERβ): Subtype-selective ligands and clinical potential

(2014) Ilaria Paterni et al.   STEROIDS

Rab5 and Ndfip1 Are Involved in Pten Ubiquitination and Nuclear Trafficking

(2014) Yijia Li et al.   TRAFFIC

SAMstrt: statistical test for differential expression in single-cell transcriptome with spike-in normalization

(2013) Shintaro Katayama et al.   BIOINFORMATICS

Quantitative single-cell RNA-seq with unique molecular identifiers

(2013) Saiful Islam et al.   NATURE METHODS

Estrogen receptor β upregulates FOXO3a and causes induction of apoptosis through PUMA in prostate cancer

(2013) P Dey et al.   ONCOGENE

Targeting estrogen receptor β in microglia and T cells to treat experimental autoimmune encephalomyelitis

(2013) Wan-fu Wu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Aggressive Prostate Cancer Is Prevented in ERαKO Mice and Stimulated in ERβKO TRAMP Mice

(2012) Anna Ślusarz et al.   ENDOCRINOLOGY

The Chaperone-assisted E3 Ligase C Terminus of Hsc70-interacting Protein (CHIP) Targets PTEN for Proteasomal Degradation

(2012) Syed Feroj Ahmed et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Estrogen Receptor β Activation Impairs Prostatic Regeneration by Inducing Apoptosis in Murine and Human Stem/Progenitor Enriched Cell Populations

(2012) Shirin Hussain et al.   PLoS One

An absence of stromal caveolin-1 is associated with advanced prostate cancer, metastatic disease spread and epithelial Akt activation

(2011) Dolores Di Vizio et al.   CELL CYCLE

The functional role of reactive stroma in benign prostatic hyperplasia

(2011) Isaiah G. Schauer et al.   DIFFERENTIATION

Estrogen receptor   and 17 -hydroxysteroid dehydrogenase type 6, a growth regulatory pathway that is lost in prostate cancer

(2011) S. Muthusamy et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

ERβ Impedes Prostate Cancer EMT by Destabilizing HIF-1α and Inhibiting VEGF-Mediated Snail Nuclear Localization: Implications for Gleason Grading

(2010) Paul Mak et al.   CANCER CELL

Cost-effectiveness of genetic testing for BRCA1 and BRCA2 mutations.

(2010) EM Ozanne et al.   CANCER RESEARCH

A role for epithelial-mesenchymal transition in the etiology of benign prostatic hyperplasia

(2009) Paloma Alonso-Magdalena et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Androgen receptor is a tumor suppressor and proliferator in prostate cancer

(2008) Y. Niu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Gamma Generalized Linear Models for Pharmacokinetic Data

(2007) Ruth Salway et al.   BIOMETRICS